Registry and analysis of Takotsubo Cardiomyopathy patients
Smidt Heart Institute Takotsubo Registry
This study is collecting information from people with Takotsubo Cardiomyopathy to see how the condition affects them and to help find better ways to treat it.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Cedars-Sinai Medical Center Academic / other |
| Locations | 1 site (Los Angeles, California) |
| Trial ID | NCT03910569 on ClinicalTrials.gov |
What this trial studies
The Cedars-Sinai Smidt Heart Institute is conducting an observational registry to collect both retrospective and prospective data on individuals diagnosed with Takotsubo Cardiomyopathy. This study aims to gather comprehensive demographic, clinical, and laboratory information, as well as therapy and outcome data, to better understand the condition. Participants will provide blood samples and clinical materials through a user-friendly online platform, allowing researchers to analyze data for identifying Takotsubo phenotypes and improving diagnostic and treatment strategies. The goal is to establish a large database that can help predict recurrence rates and develop targeted therapies.
Who should consider this trial
Good fit: Ideal candidates are individuals who have been diagnosed with Takotsubo Cardiomyopathy and can provide the necessary medical documentation.
Not a fit: Patients under 18 years old or those unable to provide informed consent or necessary documentation may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnostic capabilities and targeted treatments for patients with Takotsubo Cardiomyopathy.
How similar studies have performed: Other studies have shown success in utilizing registries for similar cardiovascular conditions, indicating a promising approach for this novel study.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Have received a diagnosis of Takotsubo from their physician and consent to enroll * Submit full medical records needed for Takotsubo adjudication Exclusion Criteria: * Younger than 18 years * Unable to provide informed consent * Unable to provide the necessary documentation needed for screening purposes
Where this trial is running
Los Angeles, California
- Cedars Sinai Medical Center — Los Angeles, California, United States (Recruiting)
Study contacts
- Study coordinator: TS Registry
- Email: takotsuboresearch@cshs.org
- Phone: 310-248-8563
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.